Robin Andrulevich
Human Resources Officer at SANA BIOTECHNOLOGY, INC.
Profile
Robin Andrulevich is currently the Director at Washington Biotechnology & Biomedical Association and the Chief People Officer & Executive Vice President at Sana Biotechnology, Inc. In the past, Andrulevich worked as a Director at Acepodia Biotechnologies, Ltd., a Principal at Amazon.com, Inc., and as the Senior Vice President-People at Juno Therapeutics, Inc. Andrulevich completed an undergraduate degree at the University of Connecticut.
Robin Andrulevich active positions
| Companies | Position | Start |
|---|---|---|
| SANA BIOTECHNOLOGY, INC. | Human Resources Officer | 2018-08-31 |
| Washington Biotechnology & Biomedical Association | Director/Board Member | 2017-11-30 |
Former positions of Robin Andrulevich
| Companies | Position | End |
|---|---|---|
| JUNO THERAPEUTICS INC | Human Resources Officer | 2018-03-31 |
Acepodia Biotechnologies, Ltd.
 Acepodia Biotechnologies, Ltd. BiotechnologyHealth Technology Acepodia Biotechnologies, Ltd. engages in the development of cell therapies to treat patients with cancers. Its business information includes biotechnology service industry, intellectual property rights, and wholesale and retail trade of chemical raw materials. The company was founded by Patrick Yang, and by Sonny Hsiao on June 19, 2017 and is headquartered in Taipei, Taiwan. | Director/Board Member | - |
| AMAZON.COM, INC. | Corporate Officer/Principal | - |
Training of Robin Andrulevich
| University of Connecticut | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| AMAZON.COM, INC. | Retail Trade |
| SANA BIOTECHNOLOGY, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
| Washington Biotechnology & Biomedical Association | |
Acepodia Biotechnologies, Ltd.
Acepodia Biotechnologies, Ltd. BiotechnologyHealth Technology Acepodia Biotechnologies, Ltd. engages in the development of cell therapies to treat patients with cancers. Its business information includes biotechnology service industry, intellectual property rights, and wholesale and retail trade of chemical raw materials. The company was founded by Patrick Yang, and by Sonny Hsiao on June 19, 2017 and is headquartered in Taipei, Taiwan. | Health Technology |
- Stock Market
- Insiders
- Robin Andrulevich
